drugset / Trial / NCT00003229
Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal
RandomizedTreatment
Summary
RATIONALE: Vaccines made from a person's white blood cells and melanoma cells may make the body build an immune response and kill the tumor cells. PURPOSE: Randomized phase I/II trial to study the effectiveness of vaccine therapy made from white blood cells and melanoma cells in treating patients with metastatic melanoma who are undergoing surgery for lymph node and tumor removal.
Timeline
- Start
- 1997-07
- Primary completion
- 2000-04
- Completion
- 2005-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | gp100 antigen | Peptide | — | Intravenous |
| Subject | tyrosinase peptide | Peptide | — | Intravenous |
| Background | aldesleukin | Protein / enzyme biologic | — | Subcutaneous |